Meta-Analysis
Copyright ©The Author(s) 2025.
World J Crit Care Med. Sep 9, 2025; 14(3): 102733
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.102733
Table 1 Baseline characteristics of the studies included in the meta-analysis, n (%)
Ref.
Study design, country
No. of patients
Age
Male sex
Etiology
Cecal diameter, in cm
Prior neostigmine
Tube placement
Nivatvongs et al[9]Retrospective, United States2256 (30-82)15 (68.2)Post-surgical: 18 (81.8); Critically ill: 4 (18.2)--0
Strodel et al[10]Retrospective, United States4459 (25-89)31 (70.4)Post-surgical: 12 (27); Critically ill: 29 (66)12.8 (9.5-17)-0
Bode et al[11]Retrospective, United States2264.3 (21-92)15 (68.2)Post-surgical: 13 (59.1); Critically ill: 9 (40.9)12.9 (10-17)-0
Fausel and Goff[12]Retrospective, United States1946-8017 (89.4)Post-surgical: 8 (42.1); Critically ill: 11 (57.9)13 (12-15)--
Lavignolle et al[13]Retrospective, France29-----15 (51.7)
Harig et al[14]Retrospective, United States2060-7812 (60)Post-surgical: 8 (40); Critically ill: 12 (60)--10 (52.6)
Jetmore et al[15]Retrospective, United States4867 (36-90)33 (68.7)Post-surgical: 27 (56); Critically ill: 21 (44)12.4-42 (87)
Geller et al[16]Retrospective, United States5068 ± 1333 (66)Post-surgical: 33 (66); Critically ill: 17 (34)13 (9-20)-42 (84)
Pham et al[17]Retrospective, United States2465 (34-85)20 (83)Post-surgical: 9 (38); Critically ill: 15 (62)12.6 ± 3.1-8 (75)
Tsirline et al[18]Retrospective, United States52------
Peker et al[19]Retrospective, Turkey5459.4 ± 15.3--10.8 ± 1.216 (30.2)-
Zhao et al[20]Prospective, China59----59 (100)-
Mankaney et al[21]Retrospective, United States8366.8 ± 16.260 (72.3)Post-surgical: 27 (32.5); Critically ill: 13 (54.2)-25 (30)-
Liu et al[22]Retrospective, United States2472.2 (51-93)19 (79.2)Post-surgical: 11 (45.8); Critically ill: 13 (54.2)12.5-14 (58.3)
Joechle et al[23]Retrospective, Germany2564 (34-86)19 (76)Critically ill: 25 (100)9 (6-13)-19 (76)
Williamson et al[24]Retrospective, United States1668 (62-84)12 (73)----
Table 2 Outcome of individual studies included in the analysis, n (%)
Ref.
No. of patients
Initial success
Overall success
Perforation
Recurrence after decompression
Need for surgery overall after successful decompression
Nivatvongs et al[9]2219 (86.4)19 (86.4)04/19 (21.0)3/22 (13.6) | 2/19 (10.5)
Strodel et al[10]4432 (72.7)34 (77.3)1 (2.3)5/34 (14.7)7/44 (15.9) | 1/34 (2.9)
Bode et al[11]2220 (91)20 (91)1 (4.5)4/20 (20)3/22 (13.6) | 2/20 (10)
Fausel and Goff [12]19-17 (89.5)03/17 (17.6)3/19 (15.8) | 2/17 (11.8)
Lavignolle et al[13]29-29 (100)07/29 (24.1)-
Harig et al[14]2018 (90)20 (100)04/20 (20)-
Jetmore et al[15]4529 (64.4)38 (84.4)1 (2.2)6/38 (15.8)5/45 (11.1)
Geller et al[16]5039 (78)44 (88)1 (2)8/44 (18.2)1/50 (2)
Pham et al[17]2422 (91)23 (95.8)0--
Tsirline et al[18]5239 (75)44 (85)1 (1.9)--
Peker et al[19]5444 (81.5)----
Zhao et al[20]5927 (45)----
Mankaney et al[21]8373 (87.9)-011 (15.1)-
Liu 2021[22]2422 (91.6)23 (95.8)1 (4.2)-1/24 (4.2) | 1/23 (4.3)
Joechle et al[23]2517 (68)-6 (24)-8/25 (32) | 0/17
Williamson et al[24]1611 (68.7)-01/11 (9.1)1/16 (6.2) | 0/11
Table 3 Summary of findings from the overall and sub-group analysis
OutcomesOverallExclusion of low-quality studies
Initial success78.8% (95%CI: 72.0-85.6), I2 = 77.0%83.4% (95%CI: 77.0-89.7), I2 = 57.8%
Overall success91.5% (95%CI: 87.0-96.0), I2 = 63.4%91.6% (95%CI: 86.4-96.8), I2 = 65.7%
Perforation0.9% (95%CI: 0.0-2.0), I2 = 0.0%0.7% (95%CI: 0.0-1.9), I2 = 0.0%
Recurrence17.1% (95%CI: 12.9-21.3), I2 = 0.0%17.6% (95%CI: 13.2-21.9), I2 = 0.0%
Need for surgery10.5% (95%CI: 5.0-15.9), I2 = 59.9%8.9% (95%CI: 3.7-14.0), I2 = 50.8%
Need for surgery after success3.7% (95%CI: 0.3-7.1), I2 = 0.0%5.2% (95%CI: 1.2-9.3), I2 = 0.0%